MorphoSys - Wikipedia, the free encyclopedia
MorphoSys AG is a German biotechnology company. It is involved in the development and research of antibodies. [1] Since 2004 it is listed on the TecDAX.
Software AG - Wikipedia, the free encyclopedia
Software AG is traded on the Frankfurt Stock Exchange’s TecDAX under the symbol “SOW ... Manz Automation · MediGene · MorphoSys · Nordex · Pfeiffer Vacuum · Phoenix Solar · Q ...
MORPHOSYS EXTENDS AGREEMENT WITH CENTOCOR. - Entrepreneur.com
MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment; TecDAX) has announced the extension of its agreement with Centocor Inc., a Johnson & Johnson company, until the ...
Daiichi Sankyo and MorphoSys Expand Collaboration With Two New Cancer ...
MARTINSRIED, Germany, May 18, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR - News; Prime Standard Segment, TecDAX) announced today the start of a further two
26.01.2010 MorphoSys Licenses HuCAL PLATINUM® Antibody Library to ...
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that it has enrolled the first patient in its Phase 1b/2a clinical trial of its lead drug MOR103. The ...
MorphoSys AG Reports Strong Results for First Quarter 2009
MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) today announced its financial results for the three months ended March 31, 2009 according to International Financial ...
MorphoSys Enrolls First Patient in Phase 1b/2a Clinical Trial for ...
MARTINSRIED, GERMANY--(Marketwire - January 19, 2010) - MorphoSys AG / MorphoSys ... MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that it has enrolled ...
MORPHOSYS/PFIZER TO DEVLOP THERAPEUTIC ANTIBODIES. - Entrepreneur.com
MorphoSys AG, Germany, (Frankfurt Stock Exchange: MOR; Prime Standard Segment) has entered into a collaboration with Pfizer Inc. for the development of therapeutic antibodies.
MorphoSys AG - Conference Call Strategic Alliance with Novartis
MorphoSys AG - Strategic Alliance with Novartis - Conference Call Manuscript Page 1 of 11 MorphoSys AG - Conference Call Strategic Alliance with Novartis December 3, 2007 The spoken ...
MorphoSys and WACKER Expand Cooperation to Use WACKER’s ESETEC ...
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and Wacker Chemie AG announced today an expansion of their existing cooperation in the use of WACKER’s bacterial secretion ...
